Price target
3,616.680.000.00%
The 28 analysts offering 1 year price forecasts for TORNTPHARM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 28 analysts giving stock ratings to TORNTPHARM in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
TORNTPHARM EPS for the last quarter is 13.40 INR despite the estimation of 14.62 INR. In the next quarter EPS is expected to reach 14.32 INR. Track more of TORRENT PHARMACEUTICALS L financials and stay on top of what is up with the company.
In the next quarter TORRENT PHARMACEUTICALS L revenue is expected to reach 29.80 B INR. Check out TORRENT PHARMACEUTICALS L revenue and earnings and make informed decisions.
According to analysts, TORNTPHARM price target is 3,616.68 INR with a max estimate of 4,232.00 INR and a min estimate of 3,090.00 INR. Check if this forecast comes true in a year, meanwhile watch TORRENT PHARMACEUTICALS L stock price chart and keep track of the current situation with TORNTPHARM news and stock market news.
We've gathered opinions of 28 analysts rating TORNTPHARM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.